AI-driven decision making in drug discovery: Leveraging human genetics, multi-omics, and real-world data to de-risk therapeutic development
03 Sept 2026
Novel Modalities & Discovery
- How are pharmaceutical companies moving beyond AI for prediction toward AI for decision-making?
- What role do human genetics and multimodal data play in improving target confidence and translational success?
- How can AI help prioritize therapeutic targets, identify liabilities earlier, and optimize portfolio decisions?
- What are the key organizational, technical, and data challenges to implementing AI effectively across R&D?
